Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Fatigue 14Neoplasms 6Brain Neoplasms 5Prostatic Neoplasms 4Depression 4Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Central Nervous System Neoplasms 2Breast Neoplasms 2Asthenia 2Recurrence 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Hematologic Neoplasms 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Cognitive Dysfunction 1Astrocytoma 1Anxiety Disorders 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Methylphenidate × Clear all
NCT03772834 2026-05-04

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT01410942 2026-02-20

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
175 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

NCT00593853 2014-06-04

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

University Health Network, Toronto

Phase 2 Terminated
33 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

NCT00138138 2007-12-10

Psychostimulants for Fatigue in Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
120 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡